HIV Long-Term Survivors End-of-Life Research

What: Qualitative study exploring the perspectives‍ of long-term HIV survivors regarding participation in end-of-life (EOL) HIV cure research.
Where: US-based, with participants recruited from Baltimore, Palm Springs, and via the Reunion Project.
When: Study published in BMC Medical Ethics (2025). Participants diagnosed ⁤largely before 1996⁢ (pre-ART).
Why it⁣ Matters: ⁣Addresses‍ ethical considerations of including vulnerable populations ‌(EOL patients) in perhaps risky, but potentially groundbreaking, HIV cure research. Highlights a willingness too participate despite limited personal benefit.
What’s Next: Informs ‍ethical guidelines for future HIV cure research involving EOL patients,⁢ emphasizing⁤ autonomy and safeguards.

Characteristic	Value
Number of Participants	16
Mean Age	68.4 years (Range: 60-82)
Gender	9 Cisgender Men, 7 Cisgender Women
Race/Ethnicity	56.25% White, 25% Black, 12.5% Indian, 6.25% Mixed Race
Geographic Region	50% West
Mean years in HIV⁢ cure ⁢Research	7.3 years (SD⁢ 9.8)
Diagnosed⁤ Before 1996	13 participants